{
  "created_at": "Sat Jul 24 2:2:36 +0000 2021",
  "id_str": "1418724292934594565",
  "full_text": "CORONAVIRUS: AstraZeneca announces that real-world data from Canada shows 82% and 87% effectiveness after one dose against hospitalisation or death caused by Beta/Gamma and Delta variants",
  "display_text_range": [
    0,
    187
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": []
  },
  "user": {
    "name": "The Spectator Index",
    "screen_name": "spectatorindex",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/1145865652533547008/XBahoZmX_normal.png"
  },
  "retweet_count": 1093,
  "favorite_count": 3110,
  "original_created_at": "Sat Jul 24 00:06:44 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "CORONAVIRUS: アストラゼネカ社は、カナダでのリアルワールドデータにより、β/γおよびδバリアントによる入院や死亡に対して、1回の投与で82%および87%の有効性が確認されたことを発表。"
    },
    {
      "locale": "zh",
      "full_text": "CORONAVIRUS。阿斯利康宣布，来自加拿大的真实世界数据显示，一剂药后对Beta/Gamma和Delta变体引起的住院或死亡有82%和87%的效果。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "CORONAVIRUS。阿斯利康宣佈，來自加拿大的真實世界數據顯示，一劑藥後對Beta/Gamma和Delta變體引起的住院或死亡有82%和87%的效果。"
    }
  ]
}